Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
Wenchao Li, Weiwei Chen, Lingyun Sun
Kidney Diseases (2021) Vol. 7, Iss. 2, pp. 79-89
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Mauro Krampera, Katarina Le Blanc
Cell stem cell (2021) Vol. 28, Iss. 10, pp. 1708-1725
Closed Access | Times Cited: 172
Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice
Wenchang Sun, Shushan Yan, Chunjuan Yang, et al.
Immunological Investigations (2022) Vol. 51, Iss. 6, pp. 1785-1803
Closed Access | Times Cited: 47
Future regenerative medicine developments and their therapeutic applications
Ahmed E. Altyar, Amr El-Sayed, Ahmed Abdeen, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114131-114131
Open Access | Times Cited: 43
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases
Lina Zaripova, Angela Midgley, Stephen E. Christmas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16040-16040
Open Access | Times Cited: 25
Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges
Yunlong Shan, Mengying Zhang, Enxiang Tao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Mesenchymal stem cells lineage and their role in disease development
Qi Xu, Wenrun Hou, Bangchuan Zhao, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 7
Expert Perspective: An Approach to Refractory Lupus Nephritis
Swati Arora, Brad H. Rovin
Arthritis & Rheumatology (2022) Vol. 74, Iss. 6, pp. 915-926
Open Access | Times Cited: 24
Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Akram Hoseinzadeh, Zahra Rezaieyazdi, Mahmoud Mahmoudi, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109699-109699
Closed Access | Times Cited: 13
Identification of cellular senescence-related genes as biomarkers for lupus nephritis based on bioinformatics
Wei Chen, Xiaofang Wang, Guoshun Huang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Potential Small Molecules for Therapy of Lupus Nephritis Based on Genetic Effect and Immune Infiltration
Jianbo Qing, Wenzhu Song, Lingling Tian, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 20
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases
Liming Li, Yong He, Junpeng Zhao, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Mesenchymal stromal cells reduce ferroptosis of podocytes by activating the Nrf2/HO-1/GPX4 pathway in lupus nephritis
Chang Liu, Xuanqi Liu, Yujiao Wang, et al.
International Immunopharmacology (2025) Vol. 153, pp. 114537-114537
Closed Access
UC-BSCs Exosomes Regulate Th17/Treg Balance in Patients with Systemic Lupus Erythematosus via miR-19b/KLF13
Jianxin Tu, Nan Zheng, Chentong Mao, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4123-4123
Open Access | Times Cited: 18
Current Progress in Treating Systemic Lupus Erythematosus Using Exosomes/MicroRNAs
Yi‐Jing Liu, Hai-bing Miao, Shu Lin, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 9
Mesenchymal stem cells in autoimmune disease: A systematic review and meta-analysis of pre-clinical studies
Hailey N. Swain, Parker D. Boyce, Bradley A. Bromet, et al.
Biochimie (2024) Vol. 223, pp. 54-73
Closed Access | Times Cited: 3
Stem cell-based therapy for systemic lupus erythematous
Maryam Zare Moghaddam, Mohammad Javad Mousavi, Somayeh Ghotloo
Journal of Translational Autoimmunity (2024) Vol. 8, pp. 100241-100241
Open Access | Times Cited: 3
Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source
Diana M. Carp, Yun Liang
Cells (2022) Vol. 11, Iss. 13, pp. 2077-2077
Open Access | Times Cited: 15
Cellular senescence in ischemia/reperfusion injury
Chaojin Chen, Muxu Zheng, Hongbiao Hou, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 15
Safety and tolerability of bone marrow–derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans
Sehwan Chun, Chan‐Bum Choi, Min S. Kim, et al.
Lupus (2022) Vol. 31, Iss. 10, pp. 1245-1253
Closed Access | Times Cited: 14
Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far
Gary S. Gilkeson
Arthritis & Rheumatology (2022) Vol. 74, Iss. 5, pp. 752-765
Closed Access | Times Cited: 13
Selective kidney targeting increases the efficacy of mesenchymal stromal/stem cells for alleviation of murine stenotic‐kidney senescence and damage
Seo Rin Kim, Kai Jiang, Xiaojun Chen, et al.
Journal of Tissue Engineering and Regenerative Medicine (2022) Vol. 16, Iss. 6, pp. 550-558
Open Access | Times Cited: 11
The role of B cells and their interactions with stromal cells in the context of inflammatory autoimmune diseases
Issam Tout, Pierre Miossec
Autoimmunity Reviews (2022) Vol. 21, Iss. 6, pp. 103098-103098
Closed Access | Times Cited: 11
Mesenchymal stem cells inhibit MRP-8/14 expression and neutrophil migration via TSG-6 in the treatment of lupus nephritis
Lingli Zhang, Weiwei Chen, Nan Xia, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 650, pp. 87-95
Closed Access | Times Cited: 6
Impact and Possible Mechanism(s) of Adipose Tissue-Derived Mesenchymal Stem Cells on T-Cell Proliferation in Patients With Rheumatic Disease
Ewa Kuca-Warnawin, Marzena Olesińska, Piotr Szczęsny, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 10
Novel and emerging treatment strategies for lupus nephritis
Desmond Y. H. Yap, Chi Chiu Mok
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 11, pp. 1283-1292
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top